Live Feed

4 - NuCana plc (0001709626) (Issuer)

6-K - Pulsenmore Ltd. (0002064764) (Filer)

8-K - CROWN CRAFTS INC (0000025895) (Filer)

IRVINE, Calif., June 24, 2026 /PRNewswire/ -- The global electric vehicle revolution has entered a new phase. For years, the EV conversation centered on range, charging speed and performance. Today, as electric vehicles move from early adopters into the mainstream, a different question is shaping consumer decisions: Who can drivers trust for the long haul? The numbers tell the story. According to the International Energy Agency (IEA), one in four new cars sold worldwide in 2025 was electric. Global EV sales surpassed 20 million units, marking the fifth consecutive year of record growth. Electric vehicles now account for approxi

Single ascending dose study evaluating safety, tolerability, and pharmacokinetics of VK3019Potential to further expand Viking's treatment options for weight lossSAN DIEGO, June 24, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today the initiation of a Phase 1 single ascending dose (SAD) clinical trial of VK3019, an investigational dual amylin and calcitonin receptor agonist (DACRA). VK3019 is being developed as a potential treatment option for weight loss. The study initiation follows the filing and clearance of VK3019's investi

Generates $11.6 Million Realized Gain from Exit of Equity Investment in Centre Technologies Holdings, LLCHOUSTON, June 24, 2026 /PRNewswire/ -- MSC Income Fund, Inc. (NYSE:MSIF) ("MSC Income" or the "Fund") is pleased to announce that it recently exited its debt investments and equity investment in Centre Technologies Holdings, LLC ("Centre" or the "Company") upon the completion of a majority recapitalization with a new financial sponsor. Founded in 2006 and headquartered in Houston, Texas, Centre is a provider of information technology (IT) services, including managed services, cloud solutions, cyber security, IT consulting and business intelligence (BI) services to lower and middle market

425 - Churchill Capital Corp XI (0002074973) (Subject)

Confirmatory study completed ahead of schedule due to strong patient demand and robust investigator interestOn track to initiate BLA in Q3 2026 under the accelerated approval pathway supporting potential approval in 2H 2027ROCKVILLE, Md., June 24, 2026 /PRNewswire/ -- REGENXBIO Inc. (NASDAQ:RGNX) today announced the successful completion of dosing in the confirmatory study of RGX-202, a potential best-in-class gene therapy for Duchenne muscular dystrophy. This milestone positions REGENXBIO to initiate a Biologics License Application (BLA) under the accelerated approval pathway in Q3 2026 for a potential approval by the U.S. Food and Drug Administration (FDA) in the second half of 2027.The BL

$272 Million in Premium Asset Sales and GrowingVenu Holding Corporation ("VENU" or the "Company") (NYSE:VENU), an owner, operator, and developer of premium live entertainment destinations, today announced that it hosted a private investor event just north of Dallas, in McKinney, Texas, featuring NFL Hall of Famer, three-time Super Bowl Champion, national spokesperson, and VENU® shareholder Troy Aikman.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624144272/en/VENU Hosts Intimate FireSuite Investor Event in McKinney, Texas Featuring Three-Time Super Bowl Champion and VENU Shareholder Troy AikmanThe event took place this past Mo

WARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with OSSIO, Inc. ("OSSIO") that brings U.S. children’s hospitals nationwide a bio-integrative, metal-free fixation technology ideally suited for treatment of fractures and deformities in pediatric patients. After performing their fixation function, OSSIOfiber® implants are gradually replaced by the patient’s newly formed bone during the natural healing process. This technological advance in material science decreases the need for hardware r

Will deliver its LVSS vehicle-based platform for the Enhanced Mobile Surveillance Capability-Lite program to secure U.S. borders Teledyne Technologies Incorporated (NYSE:TDY) announced that Teledyne FLIR Defense has won a $28.8 million contract from U.S. Customs and Border Protection (CBP), an agency of the U.S. Department of Homeland Security, to support the agency’s Enhanced Mobile Surveillance Capability–Lite (eMSC-L) program to bolster border security operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260624478803/en/Teledyne FLIR Defense has won a $28.8 million contract from U.S. Customs and Border Protection, an

10-K - CROWN CRAFTS INC (0000025895) (Filer)

3 - PLDT Inc. (0000078150) (Issuer)

8-K - Churchill Capital Corp XI (0002074973) (Filer)

Proceeds expected to support a focused pulmonary hypertension strategy, including a Phase 1b proof-of-concept study evaluating Auxora™ in PAH, with data anticipated mid-2027, and advancement of oral CRAC channel inhibitor CM5480 to IND clearance expected mid-2027Anticipated cash runway into 2H 2027 with upfront proceedsLA JOLLA, Calif., June 24, 2026 /PRNewswire/ -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced it has entered into a definitive securities purcha

Mlink chipsets expand the ecosystem for Iridium's standards-based NB-IoT and D2D connectivity MCLEAN, Va., June 24, 2026 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ:IRDM), a leading provider of global voice, data, and positioning, navigation, and timing (PNT) satellite services, today announced that Mlink Technology Inc. (Mlink), a leading fabless semiconductor company specializing in IoT and satellite communication chipsets, has begun live, on-air testing of its MS150-IR IoT-NTN chipset using Iridium NTN Direct℠. MS150-IR is a specialized version of the MS150 chipset family, developed specifically for Iridium NTN Direct as part of Mlink's global IoT-NTN product portfolio.

Nitto Denko Avecia begins first commercial-scale cGMP production of PH-762 drug substanceNewly manufactured supply will support upcoming clinical trial in next development phaseKing of Prussia, Pennsylvania--(Newsfile Corp. - June 24, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical-stage siRNA biopharmaceutical company focused on developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer, today announced that the manufacture of the first commercial-scale cGMP batch of PH-762 drug substance has commenced at Nitto Denko Avecia, Inc. Phio entered into a comprehensive drug substance services agreement with Nitto Denko Avecia, Inc. in June 2

8-K - Autonomix Medical, Inc. (0001617867) (Filer)

POS AM - ReTo Eco-Solutions, Inc. (0001687277) (Filer)

FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal care across the United StatesRAMAT GAN, Israel, June 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health, a leading provider of virtual maternity care solutions in the United States. Through the collaboration, Ouma Health will incorporate Pulsenmore's FDA-authorized home ultrasou